TipRanks
Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. (PL:SVE)
:SVE
Poland Market
SVE
Biomed-Lublin Wytwornia Surowic i Szczepionek S.A.
RESEARCH TOOLSreports

Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. (SVE) Balance Sheet

0 Followers

Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. Balance Sheet

Biomed-Lublin Wytwornia Surowic i Szczepionek S.A.'s total assets for Q2 2026 were zł295.33M, a decrease of -0.81% from the previous quarter. PL:SVE total liabilities were zł176.46M for the fiscal quarter, a -0.03% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Assets
zł 304.13Mzł 298.62Mzł 265.90Mzł 163.10Mzł 116.83M
Total Liabilities
zł 139.39Mzł 177.15Mzł 153.26Mzł 57.54Mzł 42.27M
Total Equity Gross Minority
zł 124.68Mzł 121.47Mzł 112.64Mzł 105.56Mzł 74.55M
Other Metrics
Currency in PLN

Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. Debt to Assets